LipoCoat
Company

Last deal

$1.6M
Local Amount - EUR 1.5M

Amount

Series A

Stage

16.04.2020

Date

5

all rounds

$4.3M

Total amount

General

About Company
LipoCoat developed a coating technology for medical devices that improves safety and comfort without using antibiotics or toxic substances.

Industry

Sector :

Subsector :

founded date

01.09.2016

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The LipoCoat® coatings are bio-inspired, hydrophilic, anti-fouling, multi-purpose and sustainable, making any biomaterial surface non-thrombogenic, non-fouling, and resistant towards surface pollution of microorganisms and proteins. LipoCoat's ambition is to become a leading biotech company dedicated to improving health and well-being through the discovery, development, and commercialization of novel surface solutions. The patent-based LipoCoat coating technology is applicable to a wide range of (bio)materials, only 5 nanometers thick, and has won more than 20 awards, competitions and grants, including "European Biotech Startup of 2019" and "Best Medical Device Coatings Company of 2020".
Contacts